Exact Mass: 302.1257

Cumyluron

C17H19ClN2O (302.1186)

Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.

Pyronine

C17H19N2O. Cl (302.1186)

D004396 - Coloring Agents

dehydroevodiamine hydrochloride

C19H16N3O (302.1293)

Altiloxin B

C15H23ClO4 (302.1285)

MCULE-5818670055

C15H18N4OS (302.1201)

4-[formyl(6-methoxyquinolin-8-yl)amino]pentanoic acid

C16H18N2O4 (302.1267)

3-[4-methyl-5-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-pyrrol-2-ylidenemethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionic acid|3-[4-Methyl-5-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-pyrrol-2-ylidenmethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionsaeure

C16H18N2O4 (302.1267)

CTK1D0167

C16H18N2O4 (302.1267)

6-sec-butyl-3-(4-hydroxy-benzoyl)-5-methoxy-1H-pyrazin-2-one|Septorin

C16H18N2O4 (302.1267)

plakinidine A

C18H14N4O (302.1168)

3-[4-methyl-5-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-pyrrol-2-ylidenemethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionic acid|3-[4-Methyl-5-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-pyrrol-2-ylidenmethyl)-2-oxo-2,3-dihydro-pyrrol-3-yl]-propionsaeure

C16H18N2O4 (302.1267)

Sodium Houttuyfonate

C12H23NaO5S (302.1164)

PRI_303.1340_15.8

C16H18N2O4 (302.1267)

CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1612

Tomaymycin-(DH)2-PPL hemiaminal

C16H18N2O4 (302.1267)

Oxotomaymycin-DH-PPL

C16H18N2O4 (302.1267)

SODIUM TETRAKIS(1-IMIDAZOLYL)BORATE

C12H12BN8Na (302.1176)

triphenyl(prop-2-enylidene)-λ5-phosphane

C21H19P (302.1224)

H-Arg-OtBu.2HCl

C10H24Cl2N4O2 (302.1276)

1-[2-AMINO-1-(4-TRIFLUOROMETHYL-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID

C14H17F3N2O2 (302.1242)

1-Benzyl-2-(difluoro(phenoxy)Methyl)-4,5-dihydro-1H-imidazole

C17H16F2N2O (302.1231)

methanesulfonic acid,4-phenylmethoxycyclohexan-1-ol

C14H22O5S (302.1188)

4,4,5,5-TETRAMETHYL-2-[2-(2,2,2-TRIFLUORO-ETHOXY)-PHENYL]-[1,3,2]DIOXABOROLANE

C14H18BF3O3 (302.1301)

6-(4-Methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidine

C18H14N4O (302.1168)

4,4,5,5-Tetramethyl-2-(3-methyl-5-(trifluoromethoxy)-phenyl)-1,3,2-dioxaborolane

C14H18BF3O3 (302.1301)

4-(trifluoromethoxy)benzylboronic acid pinacol ester

C14H18BF3O3 (302.1301)

2-(4-METHOXY-2-(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE

C14H18BF3O3 (302.1301)

2-Chloro-1-(8-methyl-1,2,3a,4,5,6-hexahydro-pyrazino[3,2,1-jk]carbazol-3-yl)-ethanone

C17H19ClN2O (302.1186)

[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-benzofuran-6-yl] acetate

C16H19BO5 (302.1325)

(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine

C17H19ClN2O (302.1186)

[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE

C15H24Cl2N2 (302.1316)

N-tert-butyl-6-chloro-4-(o-tolyl)nicotinamide

C17H19ClN2O (302.1186)

biphenyldiisopropylsilyl chloride

C18H23ClSi (302.1257)

2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine

C17H19ClN2O (302.1186)

Eprovafen

C18H22O2S (302.134)

4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzoic acid

C14H17F3N2O2 (302.1242)

Tritylacetic Acid

C21H18O2 (302.1307)

(RS)-4-Carboxyphenylglycine

C15H24Cl2N2 (302.1316)

8-benzyl-2,8-diazaspiro[4.5]decane

C15H24Cl2N2 (302.1316)

tert-butyl 3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carboxylate

C14H17F3N2O2 (302.1242)

5-Benzyloxytryptamine hydrochloride

C17H19ClN2O (302.1186)

(3R,5R)-benzyl 3-amino-5-(trifluoromethyl)piperidine-1-carboxylate

C14H17F3N2O2 (302.1242)

ORY-1001

C15H22N2.2(HCl) (302.1316)

(2S,5S)-3-Methyl-2-phenyl-5-(phenylMethyl)-4-IMidazolidinone hydrochloride

C17H19ClN2O (302.1186)

4,4,5,5-TETRAMETHYL-2-[3-(2,2,2-TRIFLUORO-ETHOXY)-PHENYL]-[1,3,2]DIOXABOROLANE

C14H18BF3O3 (302.1301)

6-(4-chloro-2-cyclohexylphenoxy)pyridin-3-amine

C17H19ClN2O (302.1186)

Phenol,4-[2-[4-(2-phenyldiazenyl)phenyl]diazenyl]-

C18H14N4O (302.1168)

1H-Indole-3-ethanamine,5-(phenylmethoxy)-

C17H19ClN2O (302.1186)

N2-(1H-Indol-5-yl)-6-(pyridin-4-yl)pyrazine-2,3-diamine

C17H14N6 (302.128)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

4-[(6-Phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol

C18H14N4O (302.1168)

4-(dimethylamino)benzaldehyde N-(2-furylmethyl)thiosemicarbazone

C15H18N4OS (302.1201)

2-chloro-N-[4-(N-propan-2-ylanilino)phenyl]acetamide

C17H19ClN2O (302.1186)

4-(4-Hydroxy-3-isopropylphenylthio)-2-isopropylphenol

C18H22O2S (302.134)

N,N-Diphenylpyrazolo[1,5-A][1,3,5]triazine-2,4-diamine

C17H14N6 (302.128)

4-amino-1-tert-butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-2-ium

C15H17ClN5+ (302.1172)

CID 157010227

C12H20N3O6+ (302.1352)

Pyronin Y

C17H19ClN2O (302.1186)

D004396 - Coloring Agents

5-(4-Methoxyphenyl)-7-phenyl-[1,2,4]triazolo[1,5-a]pyrimidine

C18H14N4O (302.1168)

6-(3-furanyl)-N-(3-pyridinylmethyl)-4-quinazolinamine

C18H14N4O (302.1168)

1-[4-(4-Aminophenyl)-2-thiazolyl]-4-piperidinecarboxamide

C15H18N4OS (302.1201)

5-(3-indolylidene)-N-(1-methoxypropan-2-yl)-4H-1,3,4-thiadiazin-2-amine

C15H18N4OS (302.1201)

N-[2-methoxy-4-[(2-methyl-1-oxopropyl)amino]phenyl]-2-furancarboxamide

C16H18N2O4 (302.1267)

(S,S,S)-nicotianamine monoanion

C12H20N3O6- (302.1352)

The tricarboxylic acid monoanion that is the conjugate base of (S,S,S)-nicotianamine, resulting from deprotonation of the central carboxy group and zwitterion formation of the other two. One of two major microspecies at physiological pH.

2-[[2-(3-Methyl-1-oxo-2-isoquinolinyl)-1-oxoethyl]amino]acetic acid ethyl ester

C16H18N2O4 (302.1267)

2-methyl-N-[1-(4-prop-2-enyl-5-sulfanylidene-1H-1,2,4-triazol-3-yl)ethyl]benzamide

C15H18N4OS (302.1201)

N-(7-methyl-2,5-dioxo-4,4a,6,10b-tetrahydro-3H-pyrano[3,2-c]quinolin-3-yl)propanamide

C16H18N2O4 (302.1267)

1-methyl-N-(2-naphthalenyl)-5-benzotriazolecarboxamide

C18H14N4O (302.1168)

5-(tert-butyl)-2-methyl-N-(4-nitrophenyl)-3-furamide

C16H18N2O4 (302.1267)

(E)-5-(1,2-diphenylvinyl)-2-methoxyphenol

C21H18O2 (302.1307)

4-methoxy-2-[2-[5-methoxy-2-(oxidoamino)phenyl]ethyl]-N-oxidoaniline

C16H18N2O4-2 (302.1267)

N-Acetylglycylglycylglycylglycine methyl ester

C11H18N4O6 (302.1226)

3,4-Diethynyl-1,1-dimethyl-2,5-bis(trimethylsilyl)-1-silacyclopenta-2,5-diene

C16H26Si3 (302.1342)

(1as,3r,4r,4ar,7s,8as)-7-chloro-3-hydroxy-3,4a,8,8-tetramethyl-hexahydronaphtho[1,8a-b]oxirene-4-carboxylic acid

C15H23ClO4 (302.1285)

8-(methylamino)-3,10,19-triazapentacyclo[10.7.1.0²,⁷.0⁹,²⁰.0¹³,¹⁸]icosa-1(19),2,7,9(20),11,13(18),14,16-octaen-6-one

C18H14N4O (302.1168)

4-{[4'-(aminomethyl)-[1,1'-biphenyl]-3-yl]oxy}pyrimidine-2-carbonitrile

C18H14N4O (302.1168)

8-(methylimino)-3,10,19-triazapentacyclo[10.7.1.0²,⁷.0⁹,²⁰.0¹³,¹⁸]icosa-1(20),2(7),9,11,13(18),14,16-heptaen-6-one

C18H14N4O (302.1168)

3-[(2s)-butan-2-yl]-6-(4-hydroxybenzoyl)-5-methoxy-1h-pyrazin-2-one

C16H18N2O4 (302.1267)

6-(4-hydroxybenzoyl)-5-methoxy-3-(sec-butyl)-1h-pyrazin-2-one

C16H18N2O4 (302.1267)